NCT03275116View on ClinicalTrials.gov

The Effect of Twice Daily vs. Once Daily Bronchodilation on Hyperinflation in COPD Patients During 24 Hours.

PHASE4UnknownINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

July 7, 2017

Primary Completion Date

April 30, 2020

Study Completion Date

December 31, 2020

Conditions
Chronic Obstructive Airway Disease
Interventions
DRUG

Tiotropium 'Respimat' 5 mcg

Once daily single bronchodilation

DRUG

Aclidinium Bromide/Formoterol Fumarate 340/12 mcg

Twice daily dual bronchodilation

Trial Locations (1)

6085NM

RECRUITING

Ciro, center of expertise in chronic organ failure, Horn

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

Center for Integrated Rehabilitation and Organ Failure Horn

OTHER

collaborator

AstraZeneca

INDUSTRY

lead

Maastricht University Medical Center

OTHER